WAVESENSE KEYNOTE CODELESS BLOOD GLUCOSE MONITORING SYSTEM

System, Test, Blood Glucose, Over The Counter

AGAMATRIX

The following data is part of a premarket notification filed by Agamatrix with the FDA for Wavesense Keynote Codeless Blood Glucose Monitoring System.

Pre-market Notification Details

Device IDK073573
510k NumberK073573
Device Name:WAVESENSE KEYNOTE CODELESS BLOOD GLUCOSE MONITORING SYSTEM
ClassificationSystem, Test, Blood Glucose, Over The Counter
Applicant AGAMATRIX 10 MAOR PARKWAY Salem,  NH  03079
ContactConnie Hertel
CorrespondentConnie Hertel
AGAMATRIX 10 MAOR PARKWAY Salem,  NH  03079
Product CodeNBW  
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2007-12-20
Decision Date2008-01-30
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.